Mixed-methods analysis reveals healthcare financing links to economic growth during COVID-19, suggesting reforms are needed.
The COVID-19 pandemic severely disrupted Pakistan’s healthcare system and economic stability, exposing critical vulnerabilities in healthcare financing and growth sustainability. With limited fiscal space, high out-of-pocket expenditures (60.3% of health spending), and strained medical infrastructure, the crisis underscored the need for systemic reforms. This study examines the interplay between healthcare financing and economic growth in Pakistan during the pandemic (2019–2023), Using a mixed-methods cross-sectional approach, the research integrates secondary data from the Pakistan Bureau of Statistics, State Bank of Pakistan, and WHO with primary survey responses from 170 healthcare professionals and policymakers. Regression analysis and Pearson correlation tests were employed to assess relationships between healthcare expenditure, GDP growth, and pandemic-induced disruptions. Findings reveal a significant GDP contraction (-1.5% in 2020), with partial recovery (2.0% in 2021) driven by remittances and agriculture. Public health spending rose marginally (1.2% to 1.8% of GDP), remaining below WHO benchmarks, while out-of-pocket costs strained household incomes. Regression results indicate a weak but positive correlation (r=0.32, p<0.05) between health investment and GDP recovery. Vaccination rates showed a stronger association (r=0.45, p<0.01), highlighting their role in economic stabilization. However, healthcare capacity (ICU beds, doctor density) had no significant impact, reflecting inefficiencies. The study concludes that Pakistan’s economic resilience hinges on sustainable health financing reforms, including expanded public spending (≥3% of GDP), risk-pooling mechanisms, and prioritized vaccination drives. Policy recommendations emphasize universal health coverage (UHC), equitable resource allocation, and integrated fiscal-health strategies to mitigate future shocks.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: